Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
PYXIS ONCOLOGY, INC.
About PYXS
Pyxis Oncology, Inc. is a clinical-stage company focused on developing therapeutics to target difficult-to-treat cancers. The Company is building therapeutics that hold the potential for mono and combination therapies. Its clinical program portfolio includes micvotobart pelidotin (MICVO), PYX-106, Sotigalimab (PYX-107), PYX-203, PYX-102, and APX601. The Company’s lead product candidate, MICVO, is an antibody-drug conjugate (ADC) that targets Extradomain-B Fibronectin (EDB+FN), a non-cellular structural component of the tumor extra-cellular matrix (ECM). MICVO is designed to generate a multi-pronged attack on difficult-to-treat cancers by directly killing cancer cells, reducing ECM density, inhibiting tumor angiogenesis and mobilizing an anti-tumor immune response. The Company’s ADC, MICVO, consists of human Immunoglobulin G1 (IgG1) and is site-specifically conjugated with a cleavable linker and a microtubule inhibitor (optimized auristatin) payload.
Find out what a historical investment in PYXIS ONCOLOGY, INC. would be worth today using our PYXS stock calculator.
Market Capitalisation
$121.01M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
555.99K
High today
$2.09
Low today
$1.88
Open price
$1.92
52-week high
$5.55
52-week low
$0.97
Ready to start your investing journey with Stake?
Open an accountHow do I buy PYXS shares in Australia?
Buying PYXS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in PYXIS ONCOLOGY, INC. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in PYXS
What is the ticker symbol of PYXIS ONCOLOGY, INC.?
The ticker symbol for PYXIS ONCOLOGY, INC. is PYXS.
How much is one share of PYXS?
One share of PYXS is valued at $1.98 as of 20 May 2026.
What is the market capitalisation of PYXIS ONCOLOGY, INC. PYXS?
As of 20 May 2026 PYXIS ONCOLOGY, INC. has a market cap of $121.01M.
What is the 52-week high for PYXIS ONCOLOGY, INC. stock?
The PYXIS ONCOLOGY, INC. 52-week high stock price is $5.55.
What is the 52-week low for PYXIS ONCOLOGY, INC. stock?
The PYXIS ONCOLOGY, INC. 52-week low stock price is $0.97.
Can I buy PYXS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy PYXS shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PYXS on Stake
- Buy PYXS from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of PYXS from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
PYXS related stocks